<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteHemostasis &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Mon, 06 Apr 2026 19:50:40 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/application-area/hemostasis/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>Blood Clot Dx</title>
				<link>https://wyss.harvard.edu/technology/blood-clot-dx/</link>
        <pubDate>Wed, 09 Jul 2025 17:00:40 +0000</pubDate>
        <dc:creator><![CDATA[admin]]></dc:creator>
        		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Platelet]]></category>
		<category><![CDATA[Thrombosis]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.prod.a17.io/technology/microfluidic-hemostasis-monitor/</guid>
                                                <content:encoded><![CDATA[<p>Blood clots can arise anywhere in the body, blocking blood flow and causing pain and other symptoms. The most serious types of clots, called deep vein thrombosis (DVT), typically form in the veins in the legs, and can break off and become lodged in a lung. This can cause a pulmonary embolism (PE), which is when blood flow to the lungs is prevented and can be fatal. The symptoms of PE resemble&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/blood-clot-dx/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/blood-clot-dx/</link>
          <title>Abidemi Junaid holding the microfluidic chip used to monitor blood clotting.</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/09145422/Abidemi-with-Hemostasis-Chip-Posed-08089-scaled.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=799ada1f03931c9e36620cd1d4f32f2f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagining a World Without Terminal Illness</title>
				<link>https://wyss.harvard.edu/media-post/reimagining-a-world-without-terminal-illness/</link>
        <pubDate>Mon, 16 Jun 2025 15:00:52 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Reimagine the World]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=43044</guid>
                                                <content:encoded><![CDATA[<p>As he battles metastatic skin cancer, Wyss Scientific Instrument maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of others and our planet. Credit: Wyss Institute at Harvard University&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/reimagining-a-world-without-terminal-illness/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/reimagining-a-world-without-terminal-illness/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/13093900/THUMBNAIL_Reimagining-a-World-Without-Terminal-Illness_No-Text-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=56e76b889894461a1015bc86610623b8"/></url>
				</image>
        			</item>

		
			<item>
				<title>Reimagining the World Without Terminal Illness: John Caramanica</title>
				<link>https://wyss.harvard.edu/news/reimagining-the-world-without-terminal-illness-john-caramanica/</link>
        <pubDate>Mon, 16 Jun 2025 15:00:45 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Reimagine the World]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=42949</guid>
                            <description>As he battles metastatic skin cancer, Wyss Scientific Instrument Maker John Caramanica is more motivated than ever to do his part in fabricating technologies to improve the health of others and our planet  </description>
                                        <content:encoded><![CDATA[<p>By Jessica Leff Before 5:30 AM, in the quiet stillness of the early morning, John Caramanica enters the Wyss machine shop. He turns on the devices, and while he waits for them to warm up, he proceeds one floor up to the kitchen to turn on the kettle. Once he has his tea, he sips it while sitting in the Wyss entryway, staring at the large screen, taking in news from across the Institute.</p>
<p><a href="https://wyss.harvard.edu/news/reimagining-the-world-without-terminal-illness-john-caramanica/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/reimagining-the-world-without-terminal-illness-john-caramanica/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/13093900/THUMBNAIL_Reimagining-a-World-Without-Terminal-Illness_No-Text-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=56e76b889894461a1015bc86610623b8"/></url>
				</image>
        			</item>

		
			<item>
				<title>Portable, injectable clotting agent could treat trauma victims on the front lines</title>
				<link>https://wyss.harvard.edu/news/portable-injectable-clotting-agent-could-treat-trauma-victims-on-the-front-lines/</link>
        <pubDate>Fri, 31 Jul 2020 18:00:49 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Samir Mitragotri]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=25522</guid>
                            <description>Hemostat slows internal bleeding by 97 percent in mice</description>
                                        <content:encoded><![CDATA[<p>By Leah Burrows / SEAS Communications (CAMBRIDGE, Mass) &mdash; When it comes to traumatic injuries, it&rsquo;s a race against time. A person with major hemorrhage can die from blood loss within minutes, so staunching the wound and getting them to a hospital as fast as possible is critical. Bleeding from the extremities can be slowed with compression but what about internal bleeding? In a hospital&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/portable-injectable-clotting-agent-could-treat-trauma-victims-on-the-front-lines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/portable-injectable-clotting-agent-could-treat-trauma-victims-on-the-front-lines/</link>
          <title>Samir Mitragotri’s group has developed an injectable clotting agent that could help first responders stop the wounds of hemorrhagic patients bleeding to buy them time until they reach a hospital. Credit: Camilo Jiminez/unsplash</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2020/07/31120345/camilo-jimenez-vGu08RYjO-s-unsplash.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=cfc6219dd774bcc719807f8590e66a37"/></url>
				</image>
        			</item>

		
			<item>
				<title>Sticky when wet: strong adhesive for wound healing</title>
				<link>https://wyss.harvard.edu/news/sticky-when-wet-strong-adhesives-for-wound-healing/</link>
        <pubDate>Thu, 27 Jul 2017 17:00:53 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Hydrogel]]></category>
		<category><![CDATA[Injectable]]></category>
		<category><![CDATA[Skin]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=11388</guid>
                            <description>Medical-grade bio-glue inspired by slugs sticks to biological surfaces without toxicity</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (CAMBRIDGE, Mass.) &mdash; Anyone who has ever tried to put on a Band&#x2d;Aid&reg; when their skin is damp knows that it can be frustrating. Wet skin isn&rsquo;t the only challenge for medical adhesives &ndash; the human body is full of blood, serum, and other fluids that complicate the repair of numerous internal injuries. Many of the adhesive products used today are toxic to cells&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/sticky-when-wet-strong-adhesives-for-wound-healing/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/sticky-when-wet-strong-adhesives-for-wound-healing/</link>
          <title>A new, flexible adhesive material inspired by the glue secreted by slugs adheres to biological tissues (even when wet) without causing toxicity, and can be formed into either sheets (teal blue) or custom shapes (dark blue). Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/07/24150356/Tough-adhesive-Zoom-blue.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=f910f079b8cbb51ea17f836e4ea9fa2b"/></url>
				</image>
        			</item>

		
			<item>
				<title>Pulmonary Thrombosis-on-a-Chip provides new avenue for drug development</title>
				<link>https://wyss.harvard.edu/news/pulmonary-thrombosis-on-a-chip-provides-new-avenue-for-drug-development/</link>
        <pubDate>Mon, 22 May 2017 22:45:20 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Airway-on-a-chip]]></category>
		<category><![CDATA[BIDMC]]></category>
		<category><![CDATA[Blood clotting]]></category>
		<category><![CDATA[Boston Children's Hospital]]></category>
		<category><![CDATA[Clotting]]></category>
		<category><![CDATA[DARPA]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Inflammation]]></category>
		<category><![CDATA[Lung-on-a-chip]]></category>
		<category><![CDATA[Platelet]]></category>
		<category><![CDATA[Thrombosis]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=10524</guid>
                            <description>Model of blood clot formation in the lung allows for unprecedented study of human blood responses to organ-level injury and inflammation in vitro</description>
                                        <content:encoded><![CDATA[<p>By Lindsay Brownell (BOSTON) &mdash; The average human pair of lungs is permeated by a network of about 164 feet of blood vessels (roughly the width of a football field), including microscopic blood capillaries, which facilitate the diffusion of oxygen into the bloodstream in exchange for carbon dioxide. Damage to any of those vessels can cause a blood clot, or thrombus, to form, which can cause or&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/pulmonary-thrombosis-on-a-chip-provides-new-avenue-for-drug-development/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/pulmonary-thrombosis-on-a-chip-provides-new-avenue-for-drug-development/</link>
          <title>An image of a thrombus (blood clot) formed on endothelial tissue in the pulmonary-thrombosis-on-a-chip, demonstrating the characteristic “teardrop” shape observed in vivo. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/05/22173502/Jain.TearDrop-361x241.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=24393ec0d451d83b5b8e415a3b39bdcb"/></url>
				</image>
        			</item>

		
			<item>
				<title>FDA to evaluate Organs-on-Chips</title>
				<link>https://wyss.harvard.edu/news/fda-to-evaluate-organs-on-chips/</link>
        <pubDate>Tue, 11 Apr 2017 21:00:26 +0000</pubDate>
        <dc:creator><![CDATA[Lucy Thomas]]></dc:creator>
        		<category><![CDATA[Translation News]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Emulate Inc.]]></category>
		<category><![CDATA[Kevin Kit Parker]]></category>
		<category><![CDATA[Platelet]]></category>
		<category><![CDATA[Thrombosis]]></category>
		<category><![CDATA[Vasculature]]></category>
		<category><![CDATA[Virus]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=9917</guid>
                                                <content:encoded><![CDATA[<p>Today the U.S. Food and Drug Administration (FDA) announced that it will be evaluating the organs&#x2d;on&#x2d;chips technology, originally developed at the Wyss Institute, towards identifying a more precise model for studying the effects of potential chemical and biological hazards found in foods, cosmetics or dietary supplements than is now available. The FDA will work with Emulate, Inc.</p>
<p><a href="https://wyss.harvard.edu/news/fda-to-evaluate-organs-on-chips/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/fda-to-evaluate-organs-on-chips/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/03/02152851/Human-Organs-on-Chips.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1c639de5cb3d07b94bf74ba3a766335e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Disruptive: Sports Genomics</title>
				<link>https://wyss.harvard.edu/media-post/disruptive-sports-genomics/</link>
        <pubDate>Tue, 21 Mar 2017 21:07:02 +0000</pubDate>
        <dc:creator><![CDATA[Lucy Thomas]]></dc:creator>
        		<category><![CDATA[Athletic]]></category>
		<category><![CDATA[DNA sequencing]]></category>
		<category><![CDATA[Genome]]></category>
		<category><![CDATA[George Church]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Harvard University]]></category>
		<category><![CDATA[Wyss Podcast: Disruptive]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=11701</guid>
                                                <content:encoded><![CDATA[<p>With 100 trillion cells in the human body, bacteria outnumber our own human cells 2 to 1. These bacteria make up one&rsquo;s microbiome, and particularly bacteria in our guts affect all our key organ functions. They play a role in our health, development and wellness, including endurance, recovery and mental aptitude. In this episode of Disruptive, Wyss Core Faculty member George Church and Wyss&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/disruptive-sports-genomics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/disruptive-sports-genomics/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/03/17144420/Disruptive-Sports-Genomics-e1535560597296.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=791117d7ea966310b1fba05590671185"/></url>
				</image>
        			</item>

		
			<item>
				<title>Controlling bleeding disorders with fitted hydrogel casts</title>
				<link>https://wyss.harvard.edu/news/controlling-bleeding-disorders/</link>
        <pubDate>Wed, 16 Nov 2016 19:05:58 +0000</pubDate>
        <dc:creator><![CDATA[Lucy Thomas]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Spotlights]]></category>
		<category><![CDATA[Ali Khademhosseini]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[Hydrogel]]></category>
		<category><![CDATA[Injectable]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=6665</guid>
                            <description>A hydrogel easily injected into blood vessels could help stop uncontrolled bleeding, even in patients on blood-thinners or with bleeding disorders

</description>
                                        <content:encoded><![CDATA[<p>(BOSTON) &mdash; Small blood clots called emboli are mostly known for traveling through the vasculature before they lodge and obstruct vessels, impeding blood and oxygen supply to organs like the lung. To stop excessive bleeding or the flow of blood into an aneurysm, clinicians harness the same principle by forming artificial therapeutic emboli that can plug blood&#x2d;carrying vessels.</p>
<p><a href="https://wyss.harvard.edu/news/controlling-bleeding-disorders/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/controlling-bleeding-disorders/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/11/14164019/Listing-Image-Occluded-Vessel.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=8246133144b47a56ff4b7949e2fd2cae"/></url>
				</image>
        			</item>

		
			<item>
				<title>Shear-Thinning Biomaterial: Catheter Injection</title>
				<link>https://wyss.harvard.edu/media-post/shear-thinning-biomaterial-catheter-injection/</link>
        <pubDate>Tue, 08 Nov 2016 05:00:00 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Ali Khademhosseini]]></category>
		<category><![CDATA[Blood]]></category>
		<category><![CDATA[Hydrogel]]></category>
		<category><![CDATA[Injectable]]></category>
		<category><![CDATA[Vasculature]]></category>
		<category><![CDATA[Video]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/media-post/shear-thinning-biomaterial-catheter-injection/</guid>
                                                <content:encoded><![CDATA[<p>This movie shows the solid state of the shear&#x2d;thinning biomaterial immediately after release from the catheter into an aqueous solution (00:04). The STB is cohesive and remains as one solid piece throughout the injection process. There is no noticeable dissolution of the STB into the solution, suggesting it is stable immediately after being discharged from the tip of the catheter (5F&#x2d;Beacon Tip&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/shear-thinning-biomaterial-catheter-injection/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/shear-thinning-biomaterial-catheter-injection/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2017/08/21105931/catheter-injection.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=b34f643833f9c1de9130f86fdea777b0"/></url>
				</image>
        			</item>

			</channel>
</rss>
